Literature DB >> 1713211

Clearance of chylomicron remnants by the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor.

M M Hussain1, F R Maxfield, J Más-Oliva, I Tabas, Z S Ji, T L Innerarity, R W Mahley.   

Abstract

The involvement of the low density lipoprotein receptor-related protein (LRP) in chylomicron remnant (CR) catabolism was investigated. Ligand blot analyses demonstrated that beta-very low density lipoproteins (beta-VLDL) incubated with apolipoprotein E (beta-VLDL+E) bound to the LRP and low density lipoprotein receptors, whereas active (receptor-binding) alpha 2-macroglobulin (alpha 2M) bound only to LRP partially purified from rat liver membranes. Iodinated beta-VLDL+E and active alpha 2M showed high affinity binding to the LRP/alpha 2M receptor of low density lipoprotein receptor-negative fibroblasts. The binding and degradation of radiolabeled alpha 2M by these cells were partially inhibited by beta-VLDL+E. Furthermore, alpha 2M interfered with the internalization of beta-VLDL+E and subsequent induction in the cholesterol esterification by these cells. These studies suggested that remnant lipoproteins and active alpha 2M compete for binding to the LRP/alpha 2M receptor. Next, we examined whether the LRP/alpha 2M receptor plays a role, in the presence of low density lipoprotein receptors, in the in vivo catabolism of CR in mice. In vivo studies demonstrated that the unlabeled active, but not the native, alpha 2M partially inhibited the plasma clearance and hepatic uptake of radiolabeled CR or apoE-enriched radiolabled CR. Likewise, apoE-enriched CR retarded the plasma clearance and hepatic uptake of radiolabeled active alpha 2M. These studies provide physiological evidence that the LRP/alpha 2M receptor may function as a CR receptor that removes CR from the plasma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713211

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Effect of dietary cholesterol on low density lipoprotein-receptor, 3-hydroxy-3-methylglutaryl-CoA reductase, and low density lipoprotein receptor-related protein mRNA expression in healthy humans.

Authors:  P Boucher; M de Lorgeril; P Salen; P Crozier; J Delaye; J J Vallon; A Geyssant; R Dante
Journal:  Lipids       Date:  1998-12       Impact factor: 1.880

2.  Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.

Authors:  J Fan; Z S Ji; Y Huang; H de Silva; D Sanan; R W Mahley; T L Innerarity; J M Taylor
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

Review 3.  Alcohol effects on hepatic lipid metabolism.

Authors:  Sookyoung Jeon; Rotonya Carr
Journal:  J Lipid Res       Date:  2020-02-06       Impact factor: 5.922

4.  The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro.

Authors:  I V Fuki; K M Kuhn; I R Lomazov; V L Rothman; G P Tuszynski; R V Iozzo; T L Swenson; E A Fisher; K J Williams
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

5.  Transferrin receptor targeted lipopolyplexes for delivery of antisense oligonucleotide g3139 in a murine k562 xenograft model.

Authors:  Xulang Zhang; Chee Guan Koh; Bo Yu; Shujun Liu; Longzhu Piao; Guido Marcucci; Robert J Lee; L James Lee
Journal:  Pharm Res       Date:  2009-03-17       Impact factor: 4.200

6.  The LDL receptor and LRP are receptors for beta VLDL on pigeon monocyte-derived macrophages.

Authors:  N L Jones; M Gupta; J C Lewis
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

7.  Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and the 39-kd receptor-associated protein in human trophoblasts.

Authors:  G Coukos; M E Gåfvels; S Wisel; E A Ruelaz; D K Strickland; J F Strauss; C Coutifaris
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

8.  Peroxisome proliferator-activated receptor gamma agonist rosiglitazone increases expression of very low density lipoprotein receptor gene in adipocytes.

Authors:  Takeshi Takazawa; Toshimasa Yamauchi; Atsushi Tsuchida; Makoto Takata; Yusuke Hada; Masato Iwabu; Miki Okada-Iwabu; Kohjiro Ueki; Takashi Kadowaki
Journal:  J Biol Chem       Date:  2009-08-25       Impact factor: 5.157

9.  Modulation of the low-density-lipoprotein-receptor-related protein and its relevance to chylomicron-remnant metabolism.

Authors:  A Szanto; S Balasubramaniam; P D Roach; P J Nestel
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

10.  LRP1 regulates architecture of the vascular wall by controlling PDGFRbeta-dependent phosphatidylinositol 3-kinase activation.

Authors:  Li Zhou; Yoshiharu Takayama; Philippe Boucher; Michelle D Tallquist; Joachim Herz
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.